However, recent studies have revealed certain major side effects of DPP4 inhibitors, including a significant increase in the risk of heart failure, death, myocardial infarction, stroke, and a cumulative gout incidence of 5.25% [41,42]. This evidence concerns the gene DPP4 and gout.